Press Release: Mergers: Commission clears acquisition of joint control over Actamax by DSM and DuPont

The European Commission has granted clearance under the EU Merger Regulation to the acquisition of joint control over a newly created joint venture headquartered in the US, Actamax Surgical Materials LLC ("Actamax"), by the Dutch company DSM PTG, Inc., a subsidiary of Royal DSM N.V. ("DSM"), and the US company E.I. du Pont de Nemours and Company ("DuPont"). After examining the operation, the Commission concluded that the transaction would not alter the competitive landscape as the joint venture will be active in a market different from those of its parents.